US FDA Presents 3D Printing Scenarios To Spark Discussion, Lead To Future Guidance
Executive Summary
The agency recently published a paper to spark discussions in the medtech industry on how to best regulate 3D printing of medical devices at points of care such a clinics and hospitals.
You may also be interested in...
Workshop Offers Glimpse At Future Of Hospital 3D Printing
As 3D printers become more common, they’re being pressed into service to make customized devices at the point of care. A recent US FDA/VA joint meeting revealed the promise and challenges of this approach.
McKinsey Exec On Technology Trends Reshaping Future Factories
McKinsey senior partner Joseph Hughes outlines the shape of things to come as new technologies transform life sciences manufacturing, while new modalities around cell-, gene- and RNA-based therapeutics could have “profound implications” on global operations networks.
Digital Health Roundup: Digital Therapeutics, Restoring Function, Deals, Investing And Lobbying
In this roundup feature focusing on new developments in digital health, Medtech Insight spotlights the push behind digital therapeutics, Abbott’s biowearable line, Exec Chats with iRhythm and Cognetivity, Right To Repair rules for tech, and FDA's guidance on 3D-printing.